Online Only Articles

Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia

III. Department of Medicine, Technical University of Munich, Munich
Institute of Pathology, Julius-Maximilians-University Würzburg, Munich
Institute for Medical Statistics and Epidemiology, Technical University of Munich, Munich
MLL, Munich Leukemia Laboratory, Munich
Department of Hematology and Oncology, Georg-August-University Göttingen, Munich
III. Department of Medicine, Technical University of Munich, Munich
Hematology and Oncology Pasing, Munich
Institute for Medical Statistics and Epidemiology, Technical University of Munich, Munich
Institute of Pathology Harlaching, Munich
III. Department of Medicine, Technical University of Munich, Munich;German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg
Department of Hematology and Oncology, Heinrich-Heine-University Düsseldorfand
German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg;I. Department of Medicine, Gustav-Carus-University Dresden, Dresden, Germany
III. Department of Medicine, Technical University of Munich, Munich;German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg
Vol. 99 No. 10 (2014): October, 2014 https://doi.org/10.3324/haematol.2014.104760